SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-048499
Filing Date
2014-08-11
Accepted
2014-08-11 16:10:46
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v386298_10q.htm 10-Q 447844
2 EXHIBIT 31.1 v386298_ex31-1.htm EX-31.1 7879
3 EXHIBIT 31.2 v386298_ex31-2.htm EX-31.2 7749
4 EXHIBIT 32.1 v386298_ex32-1.htm EX-32.1 4981
  Complete submission text file 0001144204-14-048499.txt   7767245

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT icpt-20140630.xml EX-101.INS 1799899
6 XBRL TAXONOMY EXTENSION SCHEMA icpt-20140630.xsd EX-101.SCH 34162
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20140630_cal.xml EX-101.CAL 32356
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20140630_def.xml EX-101.DEF 88935
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20140630_lab.xml EX-101.LAB 247009
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20140630_pre.xml EX-101.PRE 206032
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 141030673
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences